Exploration of the Mechanism of Valsartan Treatment in Chronic Renal Failure: Network Pharmacology and Experimental Validation

Figure 3

Molecular docking results (purple is the docking part). (a) Valsartan and EGFR; (b) valsartan and PTGS2; (c) valsartan and PPARG; (d) valsartan and ERBB2; (e) valsartan and ACE; (f) valsartan and STAT3; (g) valsartan and MMP9; (h) valsartan and PPARA; (i) valsartan and PTPRC; (j) valsartan and ITGB1.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)